Soo Y. Lee
Cornell University
5 Papers
8 Citations
Soo Y. Lee is an academic researcher from Cornell University. The author has contributed to research in topics: Rituximab & Metamaterial. The author has an hindex of 3, co-authored 4 publications.
Chat about Author
Papers
Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia.
Vivek Patel,Matthieu Mahévas,Soo Y. Lee,Roberto Stasi,Susanna Cunningham-Rundles,Bertrand Godeau,Julie Kanter,Ellis J. Neufeld,Tillmann Taube,Ugo Ramenghi,Shalini Shenoy,Mary J. Ward,Nino Mihatov,Vinay L. Patel,Philippe Bierling,Martin Lesser,Nichola Cooper,James B. Bussel +17 more
TL;DR: Only 21% to 26% of adults and children with chronic ITP treated with standard-dose rituximab maintained a treatment-free response for at least 5 years without major toxicity, which can inform clinical decision-making.
327
Long-Term Outcome Following B-Cell Depletion Therapy with Rituximab In Children and Adults with Immune Thrombocytopenia (ITP)
Vivek Patel,Matthieu Mahévas,Roberto Stasi,Susanna Cunningham-Rundles,Bertrand Godeau,Soo Y. Lee,Julie Kanter,Ellis J. Neufeld,Tillmann Taube,Ugo Ramenghi,Shalini Shenoy,Mary J. Ward,Nino Mihatov,Vinay L. Patel,Philippe Bierling,Nichola Cooper,James B. Bussel +16 more
TL;DR: The duration of unmaintained platelet response following rituximab treatment in 72 adults and 66 children with ITP, all of whom had had at least an initial response to ritUXimab was assessed, finding children have only a slightly higher five-year relapse-free response rate than adults.
7
Standard Dose Rituximab Plus 2–4 Cycles of Pulse Dexamethasone Is Effective and Tolerable in Treatment of Immune Thrombocytopenia (ITP)
TL;DR: Rituximab plus multiple courses of dexamethasone is active with manageable toxicity in patients with ITP and this regimen merits further exploration in a prospective trial.
1
Transmission Noise Reduction Using Duct-type Acoustic Metamaterials based on Multiple Side-branch Resonators with Varying Cross-sections
Soo Y. Lee,Joong Seok Lee +1 more
TL;DR: In this paper , the authors proposed a method to solve the problem of the lack of a suitable solution for the problem by using the concept of the "missing link" in the first place, i.e., the link between the source and the destination.
Venous thromboembolism and coagulation activity in patients with immune thrombocytopenia treated with thrombopoietin receptor agonists.
Waleed Ghanima,Soo Y. Lee,Sarah J. Barsam,Allison L. Miller,Per Morten Sandset,Per Morten Sandset,James B. Bussel +6 more
TL;DR: This paper aims to provide a history of preclinical animal data, analysis of correlative studies and review of pharmacokinetics research in a post-operative setting to help clarify the role of canine coronavirus in the development of Parkinson's disease.